Cost-Effectiveness of Vaccination of Older Adults with an MF59(®)-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden

Individuals aged 65 years and above are at increased risk of complications and death from influenza compared with any other age group. Enhanced vaccines, as the MF59(®)-adjuvanted quadrivalent influenza vaccine (aQIV) and the high-dose quadrivalent influenza vaccine (HD-QIV), provide increased prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Jorge, Biering-Sørensen, Tor, Holger Ehlers, Lars, Edwards, Christina H., Mohn, Kristin Greve-Isdahl, Nilsson, Anna, Hjelmgren, Jonas, Ma, Wenkang, Sharma, Yuvraj, Ciglia, Emanuele, Mould-Quevedo, Joaquin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145635/
https://www.ncbi.nlm.nih.gov/pubmed/37112667
http://dx.doi.org/10.3390/vaccines11040753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145635/
https://www.ncbi.nlm.nih.gov/pubmed/37112667
http://dx.doi.org/10.3390/vaccines11040753

Ejemplares similares